(Q29543531)

https://doi.org/10.1016%2FS1477-3627%2802%2902206-7

22 April 2017

author name string

Mark N. Namchuk

series ordinal

1

1 reference

https://doi.org/10.1016%2FS1477-3627%2802%2902206-7

22 April 2017

publication date

October 2002

1 reference

https://doi.org/10.1016%2FS1477-3627%2802%2902206-7

22 April 2017

0 references

1

1 reference

https://doi.org/10.1016%2FS1477-3627%2802%2902206-7

22 April 2017

issue

4

1 reference

https://doi.org/10.1016%2FS1477-3627%2802%2902206-7

22 April 2017

page(s)

125-129

1 reference

https://doi.org/10.1016%2FS1477-3627%2802%2902206-7

Chemogenomic approaches to drug discovery

22 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Transforming the genome to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Probes for chemical genomics by design

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Chemical genetics: ligand-based discovery of gene function

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

The emerging power of chemical genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR).

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Magic bullets for protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Chemical ligands, genomics and drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Chemical genomics: what will it take and who gets to play?

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Chemical genomics in the global study of protein functions

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Drug target validation: lethal infection blocked by inducible peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Chemical genetic approaches for the elucidation of signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Combinatorial informatics in the post-genomics ERA.

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

High-density miniaturized thermal shift assays as a general strategy for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

An ontology for pharmaceutical ligands and its application for in silico screening and library design

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Specificity and mechanism of action of some commonly used protein kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

HTS in the new millennium: the role of pharmacology and flexibility

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Virtual screening—an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

Recognizing molecules with drug-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS1477-3627%2802%2902206-7

7 January 2021

10.1016/S1477-3627(02)02206-7

Identifiers

DOI

1 reference

https://doi.org/10.1016%2FS1477-3627%2802%2902206-7